中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2013年
15期
907-910
,共4页
李红玲%沈涛%撒亚莲%严新民
李紅玲%瀋濤%撒亞蓮%嚴新民
리홍령%침도%살아련%엄신민
非小细胞肺癌%膜联蛋白A1%基因表达
非小細胞肺癌%膜聯蛋白A1%基因錶達
비소세포폐암%막련단백A1%기인표체
non-small cell lung carcinoma%annexin A1%gene expression
目的:检测膜联蛋白A1(annexin A1,ANXA1)在人非小细胞肺癌组织中的表达情况,并探讨其临床意义。方法:通过实时荧光定量PCR、蛋白免疫印迹和免疫组织化学技术检测非小细胞肺癌患者肺癌组织和癌旁组织(距肿瘤边缘>5 cm)中膜联蛋白A1的表达水平,并分析其与临床病理参数之间的关系。结果:实时荧光定量PCR显示,膜联蛋白A1 mRNA在肺癌组织中的表达水平(0.574±1.403)高于癌旁组织(0.240±0.893),差异具有统计学意义(t=2.060,P=0.045)。肺癌组织中膜联蛋白A1的表达与其分化程度、淋巴结转移、TNM分期相关(P<0.05);与性别、年龄、吸烟史、肿瘤直径、组织学类型无关(P>0.05)。蛋白免疫印迹和免疫组织化学结果均显示,膜联蛋白A1蛋白在肺癌组织中的表达高于癌旁组织。结论:ANXA1在非小细胞肺癌患者肺癌组织中呈高表达,可能与其发生发展和侵袭转移有一定关系。
目的:檢測膜聯蛋白A1(annexin A1,ANXA1)在人非小細胞肺癌組織中的錶達情況,併探討其臨床意義。方法:通過實時熒光定量PCR、蛋白免疫印跡和免疫組織化學技術檢測非小細胞肺癌患者肺癌組織和癌徬組織(距腫瘤邊緣>5 cm)中膜聯蛋白A1的錶達水平,併分析其與臨床病理參數之間的關繫。結果:實時熒光定量PCR顯示,膜聯蛋白A1 mRNA在肺癌組織中的錶達水平(0.574±1.403)高于癌徬組織(0.240±0.893),差異具有統計學意義(t=2.060,P=0.045)。肺癌組織中膜聯蛋白A1的錶達與其分化程度、淋巴結轉移、TNM分期相關(P<0.05);與性彆、年齡、吸煙史、腫瘤直徑、組織學類型無關(P>0.05)。蛋白免疫印跡和免疫組織化學結果均顯示,膜聯蛋白A1蛋白在肺癌組織中的錶達高于癌徬組織。結論:ANXA1在非小細胞肺癌患者肺癌組織中呈高錶達,可能與其髮生髮展和侵襲轉移有一定關繫。
목적:검측막련단백A1(annexin A1,ANXA1)재인비소세포폐암조직중적표체정황,병탐토기림상의의。방법:통과실시형광정량PCR、단백면역인적화면역조직화학기술검측비소세포폐암환자폐암조직화암방조직(거종류변연>5 cm)중막련단백A1적표체수평,병분석기여림상병리삼수지간적관계。결과:실시형광정량PCR현시,막련단백A1 mRNA재폐암조직중적표체수평(0.574±1.403)고우암방조직(0.240±0.893),차이구유통계학의의(t=2.060,P=0.045)。폐암조직중막련단백A1적표체여기분화정도、림파결전이、TNM분기상관(P<0.05);여성별、년령、흡연사、종류직경、조직학류형무관(P>0.05)。단백면역인적화면역조직화학결과균현시,막련단백A1단백재폐암조직중적표체고우암방조직。결론:ANXA1재비소세포폐암환자폐암조직중정고표체,가능여기발생발전화침습전이유일정관계。
Objective:This study aimed to detect the expression of annexin A1 in human non-small cell lung cancer (NSCLC) and to explore its clinical significance. Methods:We detected the expression levels of annexin A1 in NSCLC and the same patient's dis-tal cancerous tissue (from the edge of the tumor >5 cm) by real-time fluorescence quantitative polymerase chain reaction (real-time PCR), Western blot, and immunohistochemical methods, and then analyzed their correlation with clinical pathological parameters. Re-sults: Real-time PCR showed that the expression of annexin A1 mRNA in NSCLC was higher than that of distal cancerous tissue (0.574±1.403 vs. 0.240±0.893, t=2.060, P=0.045). Moreover, the expression of annexin A1 in NSCLC was associated with the degree of differentiation, lymph node metastasis, and TNM staging (P<0.05), but independent of gender, age, smoking history, tumor size, and histological type (P>0.05). Western blot and immunohistochemistry revealed that the expression of annexin A1 protein in NSCLC was higher than that of distal cancerous tissue. Conclusion:Annexin A1 is highly expressed in the cancer tissues of patients with NSCLC, which may be correlated with the occurrence and development of tumor and its invasion and metastasis.